Treatment of therapy-resistant auditory verbal hallucinations in schizophrenia patients by repetitive transcranial magnetic stimulation

Advances in Biological Psychiatry

Volumn 26, Issue , 2010, Pages 177-194

  Jandl, Martin ^a   Kaschka, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870286094     PISSN: 03787354     EISSN: 16622774     Source Type: Book Series    
DOI: 10.1159/000319816     Document Type: Article

References (88)

1. Sartorius N, Shapiro R, Jablonsky A: The international pilot study of schizophrenia. Schizophr Bull 1974;1:21-35.
2. Jablonsky A: Schizophrenia: The epidemiological horizon; in Hirsch SR, Weinberger DR (eds): Schizophrenia. Oxford, Blackwell Science, 1995, pp 206-256.
3. Kurachi M, Kobayashi K, Matsubara R, Hiramatsu H, Yamaguchi N, Matsuda H, Maeda T, Hisada K: Regional cerebral blood flow in schizophrenic disorders Eur Neurol 1985;24:176-181.
4. Matsuda H, Gyobu T, Ii M, Hisada K: Increased accumulation of N-isopropyl-(I-123) p-iodoamphetamine in the left auditory area in a schizophrenic patient with auditory hallucinations. J Nucl Med 1989;29:558-560.
5. Muller T, Dierks T, Fritze J, Maurer K: Mapping des EEGs - macht Halluzinationen sichtbar. Psycho 1990;16:189-192.
6. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L, Jones T, Frackowiak RSJ: A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995;378:176-179.
7. Dierks T, Linden DEJ, Jandl M, Formisano E, Goebel R, Lanfermann H, Singer W: Activation of Heschl's gyrus during auditory hallucinations. Neuron 1999; 22:615-621.
8. Lennox BR, Park SB, Jones PB, Morris PG, Park G: Spatial and temporal mapping of neural activity associated with auditory hallucinations. Lancet 1999;353:644.
9. Lennox BR, Park SB, Medley I, Morris PG, Jones PB: The functional anatomy of auditory hallucinations in schizophrenia. Psychiatry Res 2000;100:13-20.
10. Shergill SS, Bullmore E, Simmons A, Murray R, McGuire P: Functional anatomy of auditory verbal imagery in schizophrenic patients with auditory hallucinations. Am J Psychiatry 2000;157:1691- 1693.
11. Shergill SS, Cameron LA, Brammer MJ, Williams SC, Murray RM, McGuire PK: Modality specific neural correlates of auditory and somatic hallucinations. J Neurol Neurosurg Psychiatry 2001;71:688-690.
12. Bentaleb LA, Beauregard M, Liddle P, Stip E: Cerebral activity associated with auditory verbal hallucinations: A functional magnetic resonance imaging case study. J Psychiatry Neurosci 2002;27: 110-115.
13. Fitzgerald PB, Brown TL, Daskalakis ZJ: The application of transcranial magnetic stimulation in psychiatry and neurosciences research. Acta Psychiatr Scand 2002;105:324-340.
14. Tranulis C, Sepehry AA, Galinowski A, Stip E: Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A metaanalysis. Can J Psychiatry 2008;53:577-586.
15. McGuire PK, Silbersweig DA, Wright I, Murray RM, David AS, Frackowiak RS, Frith CD: Abnormal monitoring of inner speech: A physiological basis of auditory hallucinations. Lancet 1995;346:596-600.
16. Jardri R, Delevoye-Turrell Y, Lucas B, Pins D, Bulot V, Delmaire C, Thomas P, Delion P, Goeb GL: Clinical practice of rTMS reveals a functional dissociation between agency and hallucinations in schizophrenia. Neuropsychologia 2009;47:132-138.
17. Hoffman RE, Hampson M, Wu K, Anderson A, Gore J, Buchanan RJ, Constable T, Hawkins K, Sahay N, Krystal JH: Probing the pathophysiology of auditory hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation. Cerebral Cortex 2007;17:2733- 2743.
18. Hoffman RE: Auditory/verbal hallucinations, speech perception neurocircuitry, and the social deafferentation hypothesis. Clin EEG Neurosci 2008;39:87-90.
19. Rovner BW: The Charles Bonnet syndrome: A review of recent research. Curr Opin Ophtalmol 2006;17:275-277.
20. Nahas Z: Transcranial magnetic stimulation for treating psychiatric conditions: What have we learned so far? Can J Psychiatry 2008;53:553-554.
21. George MS, Belmaker RH: Historical overview; in George MS, Belmaker RH (eds): Transcranial Magnetic Stimulation in Neuropsychiatry. Washington, American Psychiatric Press, 2000, pp 1-12.
22. Barker AT, Jalinous R, Freeston IL: Non-invasive magnetic stimulation of human motor cortex. Lancet 1985;1:1106-1107.
23. Bohning DE: Introduction and overview of TMS physics; in: George MS, Belmaker RH (eds): Transcranial Magnetic Stimulation in Neuropsychiatry. Washington, American Psychiatric Press, 2000, pp 13-44.
24. Fitzgerald PB, Daskalakis ZJ: A review of repetitive transcranial magnetic stimulation use in the treatment of schizophrenia. Can J Psychiatry 2008;53: 567-576.
25. Hoffman RE, Cavus I: Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am J Psychiatry 2002; 159:1093-1102.
26. Sack AT, Linden DE: Combining transcranial magnetic stimulation and functional imaging in cognitive brain research: Possibilities and limitations. Brain Res Brain Res Rev 2003;43:41-56.
27. Post A, Keck ME: Transcranial magnetic stimulation as a therapeutic tool in psychiatry: What do we know about the neurobiological mechanisms? J Psychiatr Res 2001;35:193-215.
28. American Encephalographic Society: Guidelines for standard electrode position nomenclature. J Clin Neurophysiol 1991;8:200-222.
29. Herwig U, Satrapi P, Schoenfeldt-Lecuona C: Using the international 10-20 EEG system for positioning of transcranial magnetic stimulation. Brain Topogr 2003;16:95-99.
30. Shergill SS, Murray RM, McGuire PK: Auditory hallucinations: A review of psychological treatments. Schizophr Res 1998;32:137-150.
31. Kane JM: Clinical efficacy of clozapine in treatmentrefractory schizophrenia: An overview. Br J Psychiatry Suppl 1992;17:41-45.
32. Kane JM, Honigfeld G, Singer J, Meltzer HY: Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 1988;45:789-796.
33. Meltzer HY, Bastani B, Kwon KY, Ramirez LF, Burnett S, Sharpe J: A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report. Psychopharmacology (Berl) ;99:S68-S72.
34. Meltzer HY: Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophr Bull 1992;18:515-542.
35. Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L, Fye C, Charney D: A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. N Eng J Med 1997; 337:809-815.
36. Chong SA, Remington G: Clozapine augmentation: Safety and efficacy. Schizophr Bull 2000;26:421- 440.
37. Leucht S, Komossa K, Rummel-Kluge C, Corves C, Hunger H, Schmid F, Lobos CA, Schwarz S, Davis JM: A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry 2009;166: 152-163.
38. Miller AL, Hall CS, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Ereshefsky L, Essock SM, Finnerty M, Marder SR, Miller DD, McEvoy JP, Rush AJ, Saeed SA, Schooler NR, Shon SP, Stroup S, Tarin-Godoy B: The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry 2004;65: 500-508.
39. Elkis H: Treatment-resistant schizophrenia. Psychiatr Clin N Am 2007;30:511-533.
40. Kinon BJ, Ahl J, Stauffer VL, Hill AI, Buckley PF: Dose response and atypical antipsychotics in schizophrenia. CNS Drugs 2004;18:597-616.
41. Buckley P, Miller A, Olsen J, Garver D, Miller DD, Csernansky J: When symptoms persist: Clozapine augmentation strategies. Schizophr Bull 2001;27: 615-628.
42. Henna Neto J, Elkis H: Clinical aspects of superrefractory schizophrenia: A six-month cohort observational study. Rev Bras Psiquiatr 2007;29:228-232.
43. Meltzer HY, Rabinowitz J, Lee MA, Cola PA, Ranjan R, Findling RL, Thompson PA: Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. Am J Psychiatry 1997;154:475- 482.
44. Henna J, Oliveira JR, Mello MF, Alves TM, Eizenman IB, Elkis H: Predictors of response and outcome in treatment-resistant versus non-treatment-resistant schizophrenic patients. Schizophr Res 1999;36:281- 282.
45. Elkis H, Meltzer HY: Refractory schizophrenia. Rev Bras Psiquiatr 2007;29(suppl II):S41-S47.
46. Hoffman RE, Boutros NN, Berman RM, Roessler E, Belger A, Krystal JH, Charney DS: Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated 'voices'. Biol Psychiatry 1999;46:130-132.
47. Hoffman RE, Boutros NN, Hu S, Berman RM, Krystal JH, Charney DS: Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet 2000;355:1073-1075.
48. D'Alfonso AA, Aleman A, Kessels RP, Schouten EA, Postma A, can Der Linden, Cahn W, Greene Y, de Haan EHF, Kahn RS: Transcranial magnetic stimulation of the left auditory cortex in patients with schizophrenia: Effects on hallucinations and neurocognition. J Neuropsychiatry Clin Neurosci 2002; 14:77-79.
49. Schreiber S, Dannon PN, Goshen E, Amiaz R, Zwas TS, Grunhaus L: Right prefrontal rTMS treatment for refractory auditory command hallucinations - a neuroSPECT assisted case study. Psychiatry Res Neuroimaging 2002;116:113-117.
50. Franck N, Poulet E, Terra JL, Dalery J, d'Amato T: Left temporo-parietal transcranial magnetic stimulation in treatment-resistant schizophrenia with verbal hallucinations. Psychiatry Res 2002;120:107- 109.
51. McIntosh AM, Semple D, Tasker K, Harrison LK, Owens DG, Johnstone EC, Ebmeier KP: Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Res 2004;127:9-17.
52. Poulet E, Brunelin J, Bediou B, Bation R, Forgeard L, Dalery J, d'Amato T, Saoud M: Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biol Psychiatry 2005;57:188-191.
53. Hoffman RE, Hawkins KA, Gueorguieva R, Boutros NN, Rachid F, Carroll K, Krystal JH: Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry 2003;60:49-56.
54. Lee S-H, Kim W, Chung Y-C, Jung K-H, Bahk W-M, Jun T-Y, Kim KS, George MS, Chae JH: A doubleblind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett 2005;376:177-181.
55. National Institute of Mental Health: Special features: Rating scales and assessment instruments to use in pediatric psychopharmacology research. Psychopharmacol Bull 1985;21:839-843.
56. Hoffman RE, Gueorguieva R, Hawkins KA, Varanko M, Boutros NN, Wu Y-T, Carroll K, Krystal J: Temporoparietal transcranial magnetic stimulation for auditory hallucinations: Safety, efficacy and predictors in a fifty patient sample. Biol Psychiatry 2005;58:97-104.
57. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I): Clinician Version. Washington, American Psychiatric Publishing, 1997.
58. Delis, DC, Kramer JH, Kaplan E, Ober BA: The California Verbal Learning Test - Research Edition. San Antonio, Psychological Corporation, 1987.
59. Chibbaro G, Daniele M, Alagona G, Di Pasquale C, Cannavo M, Rapisarda V, Bella R, Pennisi G: Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations. Neurosci Lett 2005;383:54-57.
60. Fitzgerald PB, Benitez J, Daskalakis JZ, Brown TL, Marston NA, de Castella A: A double-blind shamcontrolled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. J Clin Psychopharmacol 2005;25: 358-362.
61. Saba G, Verdon CM, Kalalou K, Rocamora JF, Dumortier J, Benadhira R, Stamatiadis L, Vicaut E, Lipski H, Januel D: Transcranial magnetic stimulation in the treatment of schizophrenic symptoms: A double blind sham controlled study. J Psychiatr Res 2006;40:147-152.
62. Brunelin J, Poulet E, Bediou B, Kallel L, Dalery J, d'Amato T, Saoud M: Low frequency repetitive transcranial magnetic stimulation improves source monitoring deficit in hallucinating patients with schizophrenia. Schizophr Res 2006;81:41-45.
63. Jandl M, Steyer J, Weber M, Linden DEJ, Rothmeier J, Maurer K, Kaschka WP: Treating auditory hallucinations by transcranial magnetic stimulation: A randomized controlled crossover trial. Neuropsychobiology 2006;53:63-69.
64. Haddock G, McCarron J, Tarrier N, Faragher EB: Scales to measure dimensions of hallucinations and delusions: The Psychotic Symptom Rating Scales (PSYRATS). Psychol Med 1999;29:879-889.
65. Fitzgerald PB, Benitez J, Daskalakis JZ, De Castella A, Kulkarni J: The treatment of recurring auditory hallucinations in schizophrenia with rTMS. World J Biol Psychiatry 2006;7:119-122.
66. Poulet E, Brunelin J, Kallel L, d'Amato T, Saoud M: Maintenance treatment with transcranial magnetic stimulation in a patient in a patient with late-onset schizophrenia. Am J Psychiatry 2008;165:537-538.
67. Thirthalli J, Bharadwaj B, Kulkami S, Gangadhar BN, Kharawala S, Andrade C: Successful use of maintenance rtms for 8 months in a patient with antipsychotic-refractory auditory hallucinations. Schizophr Res 2008;100:351-352.
68. Rosa MO, Gattaz WF, Rosa MA, Rumi DO, Tavares H, Myczkowski M, Sartorelli MC, Rigonatti SP, Elkis H, Cabral SB, Teixeira MJ, Marcolin MA: Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine. J Clin Psychiatry 2007;68:1528-1532.
69. Bagati D, Nizamie SH, Prakash R: Effect of augmentatory repetitive transcranial magnetic stimulation on auditory hallucinations in schizophrenia: Randomized controlled study. Aust N Z J Psychiatry 2009;43:386-392.
70. Vercammen A, Knegtering H, Bruggeman R, Westenbroek HM, Jenner JA, Slooff CJ, Wunderink L, Aleman A: Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: A randomized controlled trial. Schizophr Res 2009;114: 172-179.
71. Schoenfeldt-Lecuona C, Groen G, Walter H, Buchler N, Wunderlich A, Spitzer M, Herwig U: RTMS for the treatment of auditory hallucinations in schizophrenia. Neuroreport 2004;15:1669-1673.
72. Sommer IE, de Weijer AD, Daalman K, Neggers SF, Somers M, Kahn RS, Slotema CW, Blom JD, Hoek HW, Aleman A: Can fMRI-guidance improve the efficacy of rTMS treatment for auditory verbal hallucinations? Schizophr Res 2007;93:406-408.
73. Dollfus S, Montagne-Larmurier A, Razafimandimby A, Allio G, Membrey JM, Delcroix N, Etard O: Treatment of auditory hallucinations by combining high-frequency repetitive transcranial magnetic stimulation and functional magnetic resonance imaging. Schizophr Res 2008;102:348-351.
74. Montagne-Larmurier A, Etard O, Razafimandimby A, Morello R, Dollfus S: Two-day treatment of auditory hallucinations by high frequency rTMS guided by cerebral imaging: A 6 month follow-up pilot study. Schizophr Res 2009;113:77-83.
75. Jardri R, Delevoye-Turrell Y, Lucas B, Pins D, Bulot V, Delmaire C, Thomas P, Delion P, Goeb JL: Clinical practice of rTMS reveals a functional association between agency and hallucinations in schizophrenia. Neuropsychologia 2009;47:132-138.
76. Jardri R, Pins D, Dubrovszky M, Lucas B, Lethuc V, Delmaire C, Vantyghem V, Despretz P, Thomas P: Neural functional organization of hallucinations in schizophrenia: Multisensory dissolution of pathological emergence in consciousness. Conscious Cogn 2009;18:449-457.
77. Loo CK, Sainsbury K, Mitchell P, Hadzi-Pavlovic D, Sachdev PS: A sham-controlled trial of left and right temporal rTMS for the treatment of auditory hallucinations. Psychol Med 2010;40:541-546.
78. Ropohl A, Sperling W, Elstner S, Tomandl B, Reulbach U, Kaltenhauser M, Kornhuber J, Maihofner C: Cortical activity associated with auditory hallucinations. Neuroreport 2004;15:523-526.
79. Fitzgerald PB, Sritharan A, Benitez J, Daskalakis ZJ, Jackson G, Kulkarni J, Egan GF: A preliminary fMRI study of the effects on cortical activation of the treatment of refractory auditory hallucinations with rTMS. Psychiatry Res 2007;155:83-88.
80. Horacek J, Brunovsky M, Novak T, Skrdlantova L, Klirova M, Bubenikova-Valesova V, Krajca V, Tislerova B, Kopecek M, Spaniel F, Mohr P, Hoschl C: Effect of low-frequency rTMS on electromagnetic tomography (LORETA) and regional brain metabolism (PET) in schizophrenia patients with auditory hallucinations. Neuropsychobiology 2007; 55:132-142.
81. Vercammen A, Knegtering H, Liemburg EJ, Boer JA, Aleman A: Functional connectivity of the temporo- parietal region in schizophrenia: Effects of rTMS treatment of auditory hallucinations. J Psychiatr Res 010, E-pub ahead of print
82. Aleman A, Sommer IE, Kahn RS: Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: A meta-analysis. J Clin Psychiatry 2007;68:416-421.
83. Martin JL: Review: Slow repetitive transcranial magnetic stimulation reduces auditory hallucinations in people with schizophrenia. Evid Based Ment Health 2007;10:114.
84. Freitas C, Fregni F, Pascual-Leone A: Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr Res 2009;108:11- 24.
85. Matheson SL, Green MJ, Loo C, Carr VJ: Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizophrenia: A systematic meta-review. Schizophr Res 2010, E-pub ahead of print. 86 Hubl D, Koenig T, Strik W, Federspiel A, Kreis R, Boesch C, Maier SE, Schroth G, Lovblad K, Dierks T: Pathways that make voices: White matter changes in auditory hallucinations. Arch Gen Psychiatry 2004;61:658-668.
86. Andoh J, Martinot JL: Interhemispheric compensation: A hypothesis of rTMS-induced effects on langua ge-related areas. Euro Psychiatry 2008;23: 281-288.
87. Pascual-Leone A, Bartrez-Faz D, Keenan JP: Transcranial magnetic stimulation: Studying the brain-behaviour by induction of 'virtual lesions'.Philos Trans R Soc Lond B Biol Sci 1999;354:1229- 1238.
88. Langguth B, Eichhammer P, Zowe M, Marienhagen J, Spiessl H, Hajak G: Neuronavigated transcranial magnetic stimulation and auditory hallucinations in a schizophrenic patient: Monitoring of neurobiologicaleffects. Schizophr Res 2006;84:185-186.